The validity of Acuros BV and TG-43 for high-dose-rate brachytherapy superficial mold treatments

Publication date: Available online 28 September 2017
Source:Brachytherapy
Author(s): Eeva L. Boman, Thomas W.S. Satherley, Nanette Schleich, Dean B. Paterson, Lynne Greig, Rob J.W. Louwe
PurposeThe purpose of this work is to validate the Acuros BV dose calculation algorithm for high-dose-rate (HDR) brachytherapy superficial mold treatments in the absence of full scatter conditions and compare this with TG-43 dose calculations. We also investigate the impact of additional back scatter material (bolus) applied above surface molds to the dose distributions under the mold.Methods and MaterialsThe absorbed dose at various depths was compared for simulations performed using either TG-43 or Acuros BV dose calculations. Parameter variations included treatment area, thickness of the bolus, and surface shape (flat or spherical). Film measurements were carried out in a flat phantom.ResultsAcuros BV calculations and film measurements agreed within 1.5% but were up to 15% lower than TG-43 dose calculations when no bolus was applied above the treatment catheters. The difference in dose at the prescription depth (1 cm below the central catheter) increased with increasing treatment area: 3.3% difference for a 3 × 3.5 cm² source loading area, 7.4% for 8 × 9 cm², and 13.4% for 18 × 19 cm². The dose overestimation of the TG-43 model decreased when bolus was added above the treatment catheters.ConclusionsThe TG-43 dosimetry formalism cannot model surface mold treatments in the absence of full scatter conditions within 5% for loading areas larger than approximately 5 × 5 cm². The TG-43 model results in an overestimation of the delivered dose, which increases with treatment area. This confirms the need for model-based dose calculation algorithms as discussed in TG-186.



http://ift.tt/2wXJz0A